These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 28721452)

  • 1. Enhanced efficacy of radiofrequency ablation for hepatocellular carcinoma using a novel vascular disrupting agent, CKD-516.
    Ham SJ; Choi Y; Lee SI; Kim J; Kim YI; Chung JW; Kim KW
    Hepatol Int; 2017 Sep; 11(5):446-451. PubMed ID: 28721452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced efficacy of CKD-516 in combination with doxorubicin: pre-clinical evaluation using a hepatocellular carcinoma xenograft model.
    Kim YI; Kim KW; Lee HK; Park J; Chung JW; Youn H; Kim SJ; Kim DH; Tseng JC; Lee JM
    Anticancer Res; 2014 Apr; 34(4):1715-22. PubMed ID: 24692701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical efficacy of metronomic chemotherapy after cool-tip radiofrequency ablation in the treatment of hepatocellular carcinoma.
    Wang-Yuan Z; Jiang-Zheng Z; Lu YD; Hao XB; Hong T; Huang F; Lei JH; He ZH; Huang MZ
    Int J Hyperthermia; 2016; 32(2):193-8. PubMed ID: 26586093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advantage of sorafenib combined with radiofrequency ablation for treatment of hepatocellular carcinoma.
    Tang Z; Kang M; Zhang B; Chen J; Fang H; Ye Q; Jiang B; Wu Y
    Tumori; 2017 May; 103(3):286-291. PubMed ID: 28058713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocellular carcinoma: concomitant sorafenib promotes necrosis after radiofrequency ablation--propensity score matching analysis.
    Fukuda H; Numata K; Moriya S; Shimoyama Y; Ishii T; Nozaki A; Kondo M; Morimoto M; Maeda S; Sakamaki K; Morita S; Tanaka K
    Radiology; 2014 Aug; 272(2):598-604. PubMed ID: 24689883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous ethanol injection enhanced the efficacy of radiofrequency ablation in the treatment of HCC: an insight into the mechanism of ethanol action.
    Tan Y; Ding X; Long H; Ye J; Huang T; Lin Y; Lv M; Xie X; Huang G
    Int J Hyperthermia; 2021; 38(1):1394-1400. PubMed ID: 34542014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative study of the effects of percutaneous ethanol injection and radiofrequency ablation in cases treated with a straight or expandable electrode.
    Kurokohchi K; Deguchi A; Masaki T; Yoneyama H; Himoto T; Miyoshi H; Mohammad HS; Taminato T; Kuriyama S
    Oncol Rep; 2007 Nov; 18(5):1275-9. PubMed ID: 17914585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sorafenib suppresses the epithelial-mesenchymal transition of hepatocellular carcinoma cells after insufficient radiofrequency ablation.
    Dong S; Kong J; Kong F; Kong J; Gao J; Ji L; Pan B; Chen L; Zheng L; Sun W
    BMC Cancer; 2015 Nov; 15():939. PubMed ID: 26620566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiofrequency ablation suppresses distant tumour growth in a novel rat model of multifocal hepatocellular carcinoma.
    Erös de Bethlenfalva-Hora C; Mertens JC; Piguet AC; Kettenbach J; Schmitt J; Terracciano L; Weimann R; Dufour JF; Geier A
    Clin Sci (Lond); 2014 Feb; 126(3):243-52. PubMed ID: 23822114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison between combination therapy of percutaneous ethanol injection and radiofrequency ablation and radiofrequency ablation alone for patients with hepatocellular carcinoma.
    Kurokohchi K; Watanabe S; Masaki T; Hosomi N; Miyauchi Y; Himoto T; Kimura Y; Nakai S; Deguchi A; Yoneyama H; Yoshida S; Kuriyama S
    World J Gastroenterol; 2005 Mar; 11(10):1426-32. PubMed ID: 15770716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammation and cancer: inhibiting the progression of residual hepatic VX2 carcinoma by anti-inflammatory drug after incomplete radiofrequency ablation.
    Jiang T; Zhang X; Ding J; Duan B; Lu S
    Int J Clin Exp Pathol; 2015; 8(11):13945-56. PubMed ID: 26823706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Percutaneous radiofrequency ablation therapy for patients with hepatocellular carcinoma during occlusion of hepatic blood flow. Comparison with standard percutaneous radiofrequency ablation therapy.
    Yamasaki T; Kurokawa F; Shirahashi H; Kusano N; Hironaka K; Okita K
    Cancer; 2002 Dec; 95(11):2353-60. PubMed ID: 12436442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypertonic saline-enhanced radiofrequency versus chemoembolization sequential radiofrequency in the treatment of large hepatocellular carcinoma.
    El-Kady NM; Esmat G; Mahmoud EH; Darweesh SK; Mahmoud SH; Elagawy WA
    Eur J Gastroenterol Hepatol; 2013 May; 25(5):628-33. PubMed ID: 23325283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergizing sunitinib and radiofrequency ablation to treat hepatocellular cancer by triggering the antitumor immune response.
    Qi X; Yang M; Ma L; Sauer M; Avella D; Kaifi JT; Bryan J; Cheng K; Staveley-O'Carroll KF; Kimchi ET; Li G
    J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33115942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Efficacy of radiofrequency ablation to treat advanced hepatocellular carcinoma].
    Wu J; Chen MH; Yang W; Wu W; Yan K
    Zhonghua Gan Zang Bing Za Zhi; 2012 Apr; 20(4):256-60. PubMed ID: 22964144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Viable hepatocellular carcinoma around retained iodized oil after transarterial chemoembolization: radiofrequency ablation of viable tumor plus retained iodized oil versus viable tumor alone.
    Kim JH; Kim PN; Won HJ; Shin YM
    AJR Am J Roentgenol; 2014 Nov; 203(5):1127-31. PubMed ID: 25341154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a radiofrequency ablation platform in a clinically relevant murine model of hepatocellular cancer.
    Qi X; Li G; Liu D; Motamarry A; Huang X; Wolfe AM; Helke KL; Haemmerich D; Staveley-O'Carroll KF; Kimchi ET
    Cancer Biol Ther; 2015; 16(12):1812-9. PubMed ID: 26537481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Randomized clinical trial of percutaneous radiofrequency ablation plus absolute ethanol injection compared with radiofrequency ablation alone for small hepatocellular carcinoma].
    Chen MS; Zhang YJ; Li JQ; Liang HH; Zhang YQ; Zheng Y
    Zhonghua Zhong Liu Za Zhi; 2005 Oct; 27(10):623-5. PubMed ID: 16438875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single hepatocellular carcinoma smaller than 2 cm: are ethanol injection and radiofrequency ablation equally effective?
    Pompili M; De Matthaeis N; Saviano A; De Sio I; Francica G; Brunello F; Cantamessa A; Giorgio A; Scognamiglio U; Fornari F; Giangregorio F; Piscaglia F; Gualandi S; Caturelli E; Roselli P; Riccardi L; Rapaccini GL
    Anticancer Res; 2015 Jan; 35(1):325-32. PubMed ID: 25550567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Priming of Sorafenib Prior to Radiofrequency Ablation Does Not Increase Treatment Effect in Hepatocellular Carcinoma.
    Bockorny B; Bullock AJ; Abrams TA; Faintuch S; Alsop DC; Goldberg SN; Ahmed M; Miksad RA
    Dig Dis Sci; 2022 Jul; 67(7):3455-3463. PubMed ID: 34297268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.